TrialJournal of diabetes investigation2023

Circulating selenoprotein P levels predict glucose-lowering and insulinotropic effects of metformin, but not alogliptin: A post-hoc analysis.

Yumie Takeshita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.